Literature DB >> 22454378

Association between reproductive factors and urinary estrogens and estrogen metabolites in premenopausal women.

Renée T Fortner1, Susan E Hankinson, Catherine Schairer, Xia Xu, Regina G Ziegler, A Heather Eliassen.   

Abstract

BACKGROUND: Little is known about relationships among reproductive factors, estrogens and estrogen metabolites (jointly referred to as EM), and estrogen metabolism patterns.
METHODS: In a cross-sectional analysis, we examined the associations of age at menarche, menstrual cycle length and regularity, parity, age at first and last birth, breastfeeding, and duration of and time since use of oral contraceptives with mid-luteal phase urinary EM in a sample of 603 premenopausal women, ages 33 to 51 years, within the Nurses' Health Study II (NHSII). Fifteen individual urinary EMs were measured with liquid chromatography/tandem mass spectrometry (LC/MS-MS) and analyzed both individually and in metabolic pathways.
RESULTS: Compared with women with extremely regular cycles, those with irregular cycles had lower levels of total EM (percent difference = 24%; P(trend) = 0.01), estradiol (23%; P(trend) = 0.02), and 16-hydroxylation pathway EM (32%; P(trend) < 0.01). Longer menstrual cycles were associated with higher levels of estrone (percent difference ≥32 vs. <26 days: 25%; P(trend) = 0.03), estradiol (24%; P(trend) = 0.01), and 16-hydroxylation pathway EM (22%; P(trend) = 0.02). Among parous women, older age at first birth was associated with lower 16-hydroxylation pathway EM (percent difference age at first birth >35 vs. ≤25 years: 20%; P(trend) = 0.02). The other reproductive factors were not statistically significantly associated with individual urinary EM or EM pathways. CONCLUSIONS AND IMPACT: These data, based on a LC/MS-MS assay with high specificity and precision, provide an initial, comprehensive evaluation of the associations between reproductive factors and estrogen metabolism patterns.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22454378      PMCID: PMC3381957          DOI: 10.1158/1055-9965.EPI-12-0171

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  34 in total

1.  Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women.

Authors:  A Heather Eliassen; Donna Spiegelman; Xia Xu; Larry K Keefer; Timothy D Veenstra; Robert L Barbieri; Walter C Willett; Susan E Hankinson; Regina G Ziegler
Journal:  Cancer Res       Date:  2011-12-05       Impact factor: 12.701

Review 2.  Epidemiology of breast cancer.

Authors:  T J Key; P K Verkasalo; E Banks
Journal:  Lancet Oncol       Date:  2001-03       Impact factor: 41.316

Review 3.  A new approach to measuring estrogen exposure and metabolism in epidemiologic studies.

Authors:  R G Ziegler; J M Faupel-Badger; L Y Sue; B J Fuhrman; R T Falk; J Boyd-Morin; M K Henderson; R N Hoover; T D Veenstra; L K Keefer; X Xu
Journal:  J Steroid Biochem Mol Biol       Date:  2010-04-09       Impact factor: 4.292

4.  Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women.

Authors:  P Muti; H L Bradlow; A Micheli; V Krogh; J L Freudenheim; H J Schünemann; M Stanulla; J Yang; D W Sepkovic; M Trevisan; F Berrino
Journal:  Epidemiology       Date:  2000-11       Impact factor: 4.822

5.  Circulating estrogen metabolites and risk for breast cancer in premenopausal women.

Authors:  Alan A Arslan; Roy E Shore; Yelena Afanasyeva; Karen L Koenig; Paolo Toniolo; Anne Zeleniuch-Jacquotte
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08       Impact factor: 4.254

6.  Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.

Authors:  T Key; P Appleby; I Barnes; G Reeves
Journal:  J Natl Cancer Inst       Date:  2002-04-17       Impact factor: 13.506

7.  Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal women.

Authors:  A Heather Eliassen; Regina G Ziegler; Bernard Rosner; Timothy D Veenstra; John M Roman; Xia Xu; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-20       Impact factor: 4.254

Review 8.  C2- and C4-position 17beta-estradiol metabolites and their relation to breast cancer.

Authors:  Annie Joubert; Hermia Van Zyl; Johannes Laurens; Mona-Liza Lottering
Journal:  Biocell       Date:  2009-12       Impact factor: 1.254

9.  Premenopausal endogenous oestrogen levels and breast cancer risk: a meta-analysis.

Authors:  K Walker; D J Bratton; C Frost
Journal:  Br J Cancer       Date:  2011-09-13       Impact factor: 7.640

10.  Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women.

Authors:  F Clavel-Chapelon
Journal:  Br J Cancer       Date:  2002-03-04       Impact factor: 7.640

View more
  10 in total

1.  Estrogen Metabolism in Premenopausal Women Is Related to Early Life Body Fatness.

Authors:  A Heather Eliassen; Regina G Ziegler; Lauren C Houghton; Julia S Sisti; Susan E Hankinson; Jing Xie; Xia Xu; Robert N Hoover
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-03-06       Impact factor: 4.254

2.  Menstrual cycle characteristics and steroid hormone, prolactin, and growth factor levels in premenopausal women.

Authors:  Leslie V Farland; Fan Mu; A Heather Eliassen; Susan E Hankinson; Shelley S Tworoger; Robert L Barbieri; Mitch Dowsett; Michael N Pollak; Stacey A Missmer
Journal:  Cancer Causes Control       Date:  2017-10-31       Impact factor: 2.506

3.  Alcohol Consumption and Urinary Estrogens and Estrogen Metabolites in Premenopausal Women.

Authors:  Terryl J Hartman; Julia S Sisti; Susan E Hankinson; Xia Xu; A Heather Eliassen; Regina Ziegler
Journal:  Horm Cancer       Date:  2016-01-04       Impact factor: 3.869

4.  Body size in relation to urinary estrogens and estrogen metabolites (EM) among premenopausal women during the luteal phase.

Authors:  Jing Xie; A Heather Eliassen; Xia Xu; Charles E Matthews; Susan E Hankinson; Regina G Ziegler; Shelley S Tworoger
Journal:  Horm Cancer       Date:  2012-08-04       Impact factor: 3.869

5.  Dietary Fat and Fiber Intakes Are Not Associated with Patterns of Urinary Estrogen Metabolites in Premenopausal Women.

Authors:  Hannah Oh; Stephanie A Smith-Warner; Rulla M Tamimi; Molin Wang; Xia Xu; Susan E Hankinson; Barbara J Fuhrman; Regina G Ziegler; A Heather Eliassen
Journal:  J Nutr       Date:  2015-07-15       Impact factor: 4.798

6.  Urinary concentrations of estrogens and estrogen metabolites and smoking in caucasian women.

Authors:  Fangyi Gu; Neil E Caporaso; Catherine Schairer; Renee T Fortner; Xia Xu; Susan E Hankinson; A Heather Eliassen; Regina G Ziegler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-25       Impact factor: 4.254

7.  Reproductive and hormonal factors and the risk of lung cancer: the EAGLE study.

Authors:  Angela Cecilia Pesatori; Michele Carugno; Dario Consonni; Neil E Caporaso; Sholom Wacholder; Margaret Tucker; Maria Teresa Landi
Journal:  Int J Cancer       Date:  2012-11-26       Impact factor: 7.396

8.  Urinary estrogens and estrogen metabolites and mammographic density in premenopausal women.

Authors:  Kimberly A Bertrand; A Heather Eliassen; Susan E Hankinson; Gretchen L Gierach; Xia Xu; Bernard Rosner; Regina G Ziegler; Rulla M Tamimi
Journal:  Breast Cancer Res Treat       Date:  2012-09-28       Impact factor: 4.624

9.  Associations of Breast Cancer Risk Factors with Premenopausal Sex Hormones in Women with Very Low Breast Cancer Risk.

Authors:  Lauren C Houghton; Davaasambuu Ganmaa; Philip S Rosenberg; Dambadarjaa Davaalkham; Frank Z Stanczyk; Robert N Hoover; Rebecca Troisi
Journal:  Int J Environ Res Public Health       Date:  2016-10-31       Impact factor: 3.390

10.  Maternal phthalate and phthalate alternative metabolites and urinary biomarkers of estrogens and testosterones across pregnancy.

Authors:  Diana C Pacyga; Joseph C Gardiner; Jodi A Flaws; Zhong Li; Antonia M Calafat; Susan A Korrick; Susan L Schantz; Rita S Strakovsky
Journal:  Environ Int       Date:  2021-06-08       Impact factor: 13.352

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.